PTC Therapeutics Provides a Corporate Update and Reports Second Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. ISRG
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to PTC Therapeutics Provides a Corporate Update and Reports Second Quarter Financial Results

PTC Therapeutics (PTCT) Misses Q2 EPS by 76c

August 4, 2022 5:15 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($2.13), $0.76 worse than the analyst estimate of ($1.37). Revenue for the quarter came in at $166 million versus the consensus estimate of $162.12 million.

GUIDANCE:

PTC Therapeutics sees Q3 2022 revenue of $700-750 million, versus the consensus... More